Startseite>>Lipids>> Prostaglandins>>15(R),19(R)-hydroxy Prostaglandin F2α

15(R),19(R)-hydroxy Prostaglandin F2α (Synonyms: 15(R),19(R)hydroxy PGF2α)

Katalog-Nr.GC40532

19(R)-Hydroxylated prostaglandins (PGs) occur in μg/ml concentrations in the semen of certain mammalian species, especially primates.

Products are for research use only. Not for human use. We do not sell to patients.

15(R),19(R)-hydroxy Prostaglandin F2α Chemische Struktur

Cas No.: 1224444-23-8

Größe Preis Lagerbestand Menge
50μg
54,00 $
Auf Lager
100μg
101,00 $
Auf Lager
500μg
425,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

19(R)-Hydroxylated prostaglandins (PGs) occur in µg/ml concentrations in the semen of certain mammalian species, especially primates. In the case of humans, the compounds are primarily of the PGE series, and the hydroxyl stereochemistry is 15(S),19(R). 19(R)-Hydroxylated PGs are also found in the seminal plasma of marsupials, where F-type compounds of the 1 and 2-series predominate. The 15(R)-hydroxy epimer of these 19-hydroxylated PGs is the inverse or "unnatural" isomer at C-15. The biological role of 19(R)-hydroxylated PGs is not well established. In the F-series, 19(R)-hydroxylation is associated with a significant loss of receptor-mediated biological activity in some assays.

Bewertungen

Review for 15(R),19(R)-hydroxy Prostaglandin F2α

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 15(R),19(R)-hydroxy Prostaglandin F2α

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.